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ABSTRACT 
 
Introduction and hypotheses: Gene polymorphisms that are suspected of playing a role in the 
development of childhood onset depression are examined in our work. Furthermore, we examine 
symptoms or symptom groups that can be considered as homogeneous types or endophenotypes 
of depression, and can be associated with the investigated genotypes or alleles. Oxytocin (OXT) 
and prolactin (PRL) are neuropeptide hormones that interact with the serotonin system and are 
involved in the stress response and social affiliation. In human studies, serum OXT and PRL 
levels have been associated with depression and related phenotypes. Both brain-derived 
neurotrophic factor (BDNF) polymorphisms and interferon-gamma +874 T/A polymorphism 
have been examined for their contribution to depression with equivocal results. More 
homogeneous phenotypes might be used to improve our understanding of genetic liability to 
depression.  
The aim of our work was to 1) determine if single nucleotide polymorphisms (SNPs) at the loci 
for OXT and PRL and their receptors, OXTR and PRLR, were associated with childhood-onset 
mood disorders (COMD). 2) to test for association between BDNF Val66Met polymorphism and 
childhood onset melancholic depression and 3) to investigate the interferon-gamma +874 T/A 
polymorphism and the somatic type of depression.  
We also examined the interactive effects of stressful life events (SLE) and the Val66Met 
polymorphism on the risk of childhood onset melancholic depression.  
Materials and Methods: Using 678 families in a family-based association design, we genotyped 
16 SNPs at OXT, PRL, OXTR and PRLR to test for association with COMD. Examining the 
BDNF, in the preliminary studies and the following case-control studies, first subsets, then a 
sample of 583 depressed probands were involved (55 from the somatic type of depression, 162 of 
the melancholic subtype). Diagnoses were derived via the Interview Schedule for Children and 
Adolescents - Diagnostic Version and life event data were collected by means of an Intake 
General Information Sheet.  
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Results: No significant associations were found for SNPs in the OXTR, PRL, or PRLR genes. 
Two of three SNPs of the OXT gene were associated with COMD (p=0.02), significant after 
spectral decomposition, but were not significant after additionally correcting for the number of 
genes.  
In the „preliminary BDNF study”, regarding the melancholic subtype, BDNF Val66Val genotype 
had a significantly higher frequency in the melancholic depressed group than in the controls 
(p=0.024). In the study examining the whole sample of depressed probands, 27.8% of the 
participants met criteria for melancholy. In the melancholic group the proportion of the females 
was higher (53.1%), though there were more males in the overall depressed sample. We detected 
no significant differences in genotype or allele frequency between the melancholic and the non-
melancholic depressed group. BDNF Val66Met polymorphism and stressful life event interaction 
was not significantly associated with the melancholy outcome.  
Regarding the association of somatic type of depression and the interferon-gamma +874 T/A 
polymorphism, the frequencies of the A allele containing genotypes were higher in the somatic 
subtype, than in the comparison group, without statistically significant difference (T/A: SB 
(sickness behaviour) group: 60.0%, comparison group: 51.1%; A/A: SB group: 21.8%, 
comparison group: 13.3%; p=0.122). The comparison of allele frequencies also did not reveal 
statistically significant differences (T: SB group: 48.2%, comparison group: 61.1%; A: SB 
group: 51.8%, comparison group: 38.9%; p>0.1).  
Conclusion: In our study, females were more prone to develop the early-onset melancholic 
phenotype. The present work is the first genetic analysis to examine the association between 
variants in the oxytocin and prolactin neuroendocrine genes and depression with onset in 
childhood. To our knowledge, this is also the first study to investigate the differentiating effect of 
the genotype and the G×E interaction on melancholic phenotype in a large sample of depressed 
young patients. We didn’t find association between the melancholic subtype of major depression 
and the BDNF genotype and stressful life event interaction and the somatic subtype of 
childhood-onset major depression and the interferon-gamma +874 T/A polymorphism in this 
large sample, which is representative to the Hungarian clinic-referred population of depressed 
youths.   
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1. Introduction 
1.1. Background 
Major depressive disorder (MDD) is a major public health problem representing the leading 
cause of disability in developed countries and the fourth leading cause of disability worldwide. 
Lifetime risk for developing MDD is estimated to be approximately 15% (Kessler et al., 2003). 
Mortality risk of depressed patients is two times greater than that of the general population due to 
direct (suicide) and indirect causes (Cuijpers and Smit, 2002). 
It is well documented that MDD is most likely resulted from complex interactions of genetic, 
epigenetic, environmental and developmental factors, nevertheless the exact mechanisms 
underlying the disease are still largely unknown (e.g. Ebmeier et al., 2006). There is fairly 
consistent evidence that childhood onset depression (COD) has familial determinants (Rice et al., 
2002). For example, in a large twin study the hereditability for MDD was 29% in males and 42% 
in females, respectively (Kendler et al., 2006). Levinson (2006) estimated the genetic 
contribution to the development of MDD as 40-50%.  
To achieve the goal of developing more effective treatment for MDD, a greater understanding of 
the neurobiology of psychopathology and the identification of the risk and resilience factors are 
needed.  
 
1.2. Putative genetic liability to depression 
 
1.2.1. Oxytocin and prolactin genes 
 
 Molecular genetic studies of depression-related phenotypes in paediatric samples are relatively 
few in number, with many focused on serotonin system genes. Genetic association studies of 
variants in the serotonin transporter (SLC6A4) and serotonin receptor (e.g. 5HT1A, 1B, 2A) 
genes have found weak, inconsistent associations with depression (Lemonde et al., 2003; Parsey 
et al., 2006; Huang et al., 2004; Caspi et al., 2003; Lotrich and Pollock, 2004; Surtees et al., 
2006; McMahon et al., 2006). This suggests that genes outside of the serotonergic system, may 
also be important in the aetiology of depressive disorders such as childhood-onset mood disorder 
(COMD). Oxytocin (OXT) and prolactin (PRL) are neuropeptide hormones that have been 
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shown to be associated with antidepressant activity, to interact with the serotonin system and to 
be involved in the stress response and the formation of social bonds.  
Oxytocin has been proposed to balance the suppression of the serotonergic system by the 
hypothalamic–pituitary–adrenal axis (HPA) following stressful events (Legros, 2001) and reduce 
anxiety (Domes et al., 2007). Evidence from animal and human investigation supports the notion 
of a relationship between oxytocin and serotonin systems (Emiliano et al., 2007; Lee et al., 2003; 
Amico et al., 2004). Published studies suggest that stress and fear induce compensatory (Windle 
et al., 2004; Ebner et al., 2005; Kirsch et al., 2005) changes in OXT expression. Human 
biomarker studies provide another line of evidence implicating oxytocin in depressive symptoms 
(Zetzsche et al., 1996; Bell et al., 2006; Scantamburlo et al., 2007; Cyranowski et al., 2008; 
Costa et al., 2009).  
Prolactin secretion is also dependent on the serotonergic system. Human serum PRL levels have 
been shown to reflect serotonergic function via D-fenfluramine challenge (Lee et al., 2003; 
Mann et al., 1995). Studies show that the prolactin response to D-fenfluramine and serotonergic 
agents is blunted in depressed individuals compared to controls (Mann et al., 1995; Heninger et 
al., 1984; Golden et al., 1992; Anderson et al., 1992; Papakostas et al., 2006). Several papers 
show stress-induced increases in PRL (Drago et al., 1990; Bodnár et al., 2004; Torner et al., 
2004). The postpartum antidepressant-like effects of lactation may be mediated by the parity of 
the mother (Sibolboro Mezzacappa and Endicott, 2007). Plasma PRL levels in response to 
tryptophan challenge are associated with neuroticism, a correlate of depressive disorders 
(Brummett et al., 2008). Still other results support an OXT-PRL feedback loop in the 
hypothalamus (Liu and Ben-Jonathan, 1994; Kokay et al., 2006).  
 
1.2.2. BDNF gene 
Numerous other candidate genes have been studied as potential risk factors for COD (Rice, 
2010), including the BDNF locus. BDNF Val66Met is a SNP of nucleotide 196 in exon 5, 
resulting in a Val/Met amino acid change in codon 66, affecting the pro-BDNF sequence, with 
no functional effect on the mature BDNF, but causing changes in its cellular transport and 
secretion.  
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Figure 1. BDNF polymorphism 
 
 
The encoded protein is a neurotrophin, playing a role in hippocampal dendritic morphology and 
synaptic function. It has been implicated in depression, evidenced by decreased hippocampal 
volume and hippocampal and serum BDNF levels associated with the disease. (Savitz and 
Drevets, 2009; Sen et al., 2008, Cardoner et al., 2013). The presence of the Val66Met Met allele 
has been associated with inefficient secretion of BDNF regardless of gender (Egan et al., 2003; 
Ozan et al., 2010) and decreased serum BDNF levels were found in patients with depression 
(Ozan et al., 2010).  
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Figure 2. Cellular transport and secretion of BDNF 
 
In a sample of adults with a history of childhood onset mood disorder (COMD) (Strauss et al., 
2004) the BDNF Val66Met-(GT)n two marker Val/short (<170 bp) haplotype was associated with 
COMD, but no significant association was found between the examined BDNF polymorphisms 
and childhood-onset mood disorder by allelic or genotypic analysis. In another study, the same 
authors examined a sample of 258 Hungarian trios including juvenile probands with COMD and 
found the BDNF Val66Met Val allele to be associated with the disorder (Strauss et al., 2005). 
Importantly, the present study is performed on a subset of the same Hungarian sample. 
Noteworthy, a meta-analysis of Chen et al. (2008) did not confirm the association between 
Val66Met polymorphism and depression. Also, in contrast to the often reported association 
between the BDNF polymorphism and depression, the meta-analysis of Verhagen et al. (2010) 
suggests only a gender-dependent role of the polymorphism in the development of depression, as 
significant association was found only in males. 
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1.2.3 Inflammatory cytokine gene variant 
 It is known that the genetic variants of inflammatory cytokines can play a role in the appearance 
of depression (Misener et al., 2008). In a previous study, increased interferon-gamma (IFNγ) 
level was found in a sample of adolescents with major depression (Gabbay et al., 2009). Another 
study showed that the increase in the level of interferon-gamma correlates with the interferon-
gamma +874 T/A single nucleotide polymorphism (Pravica et al., 2000). 
1.3. Factors which may influence the link between genetic liability and depression 
1.3.1. Melancholic phenotype of depression 
 In this work a number of factors are considered that could contribute to and/or moderate the 
liability to depression. The limited success of genetic studies might arise from current 
classification schemas including DSM-IV, since they are based on clusters of syndromes in a 
heterogeneous patient group (Hasler et al., 2004). MDD as defined in DSM-IV is a 
heterogeneous disorder with regard to etiology, symptoms and level of functioning and response 
to treatment (Domschke et al., 2010).  
One of the clinical subtypes of MDD that showed distinct clinical (Kessler et al., 1997b) and 
biochemical (Maes et al., 1990) features was melancholic depression (Gold et al. 2002). Schotte 
et al. (1997) provided the validation through cluster analysis of melancholic and non-
melancholic subtypes of unipolar depression.  
A promising attempt has been made to determine the nosological status and diagnostic strategies 
to melancholia (Parker and Paterson, 2014). Furthermore, several biological markers have been 
suggested to identify this putative endophenotype. The preliminary results of Bracht et al., 
(2013) suggest that the melancholic subtype of MDD is characterized by white matter 
microstructure alterations of the medial forebrain bundle compared to healthy controls, while it 
did not differ between the healthy controls and the overall MDD sample. Though some studies 
claim that psychomotor retardation is a feature of depression (Widlöcher et al., 1983, Dantchev, 
1998), some authors suggested that psychomotor retardation allows determining putative 
endophenotypes such as melancholy (Bennabi et al., 2013, Parker et al., 1996). Preliminary 
evidence suggests that genetic factors may discriminate melancholic and non-melancholic 
depression in a putatively interesting preliminary study of Quinn et al. (2012) with low sample 
16 
 
 
size. The authors (Quinn et al., 2012) found that the BDNF rs6265 Met allele predisposes non-
melancholic depression and the interaction of the BDNF rs6265 Met allele and stressful life 
event (SLE) predicts non-melancholia over main effects. Furthermore, in a study of Patas et al. 
(2014) investigating the association between serum brain-derived neurotrophic factor and plasma 
interleukin-6 in major depressive disorder, plasma interleukin-6 was found to be a positive 
predictor of BDNF only in the melancholic sample. According to Harkness et al. (2006) subjects 
with severe melancholic depression are more sensitive to stress, with episodes being influenced 
by more minor stressors than those of non-melancholic patients. 
 
1.3.2. Somatic type of depression 
 Another putatively interesting phenotype is the somatic type of depression (STOD). 
Inflammatory cytokines induce behavioural symptoms, known as sickness behaviour (SB), that 
are similar to symptoms seen in depression (fatigue, altered sleep patterns, psychomotor 
retardation, social withdrawal, appetite loss, anhedonia and impaired cognitive function). INF-γ 
is primarily secreted by T-lymphocytes, it usually provokes fatigue, malaise, headache, lack of 
appetite, weight loss, weakness, lethargy and decreased concentration, which can all be 
symptoms of depression (Fent et al., 1987, Triozzi et. al., 1990). This similarity led to the theory 
that the imbalance of inflammatory cytokines can contribute to the development of depression. 
 
1.3.3. Role of stressful life events 
 Indeed, the role of stressful life events has been proven in depression (Kessler et al., 1997a) and 
several studies showed the effect of gene by environment (G×E) interaction on mood disorders.  
Many environmental factors have been identified, including early and recent stressful life events 
(Caspi et al., 2003) and parental depression (Bouma et al., 2008), which may interact with the 
genetic background (Ebmeier et al., 2006).  For example, the short allele of the serotonin 
transporter 5-HTTLPR polymorphism compared to the long allele exhibited more depression and 
suicidality in relation to stressful life events in a number of studies (Caspi et al., 2003, Kaufman 
et al., 2004, Eley et al., 2004).  Although this association was not confirmed in the meta-analysis 
of Risch et al. (2009), it thus seems that MDD is caused by numerous interacting genetic and 
non-genetic factors. 
17 
 
 
In a study of Bukh et al. (2009) the Met allele of the BDNF Val66Met polymorphism was 
independently associated with the presence of SLEs prior to the onset of depression and in a 
paper of Elzinga et al. (2011) BDNF Met allele carriers were found to be sensitive to early SLEs. 
Kim et al. (2007) found significant interaction of stressful life events and BDNF Met/Met and 
Val/Met genotypes on the risk of depression. In a study of Chen et al. (2012) on a sample of 780 
pairs of ethnic Han Chinese adolescent twins, authors found that the BDNF Val allele modulates 
the influence of environmental stress on depression. Interaction between BDNF Val66Met 
polymorphism and environmental stress on depression was found even when separating pure 
environmental factors from the environmental factors under partial genetic control and adopting 
a prospective longitudinal design (Chen et al., 2013). In a study of Hosang et al. (2014) the Met 
allele of BDNF significantly moderates the relationship between life stress and depression, the 
association being stronger for an interaction with stressful life events and weaker for interaction 
of BDNF Val66Met with childhood adversity. In the study of Brown et al. (2014) the Met alleles 
of BDNF Val66Met significantly moderated the relationship between recent life events and adult 
onsets of depression, though BDNF did not significantly influence the effect of childhood 
maltreatment on chronic depression. 
 
An illustrative example of how difficult it is to find replicable gene-MDD associations is 
provided by a study by Bosker and colleagues (2011). In their meta-analysis of 92 single 
nucleotide polymorphisms from 57 candidate genes previously reported to be significantly 
associated with MDD only four SNPs from four genes were found to replicate. Even these 
associations may turn out to be false positives due to multiple testing.  
Genome wide association studies, up to date best suited for detecting variants with minor effect 
(Shyn et al., 2010) haven’t shown genome-wide significant findings, though their non-significant 
top signals may be promising. Top signals may point to the possible role of synaptic processes in 
the genetic background of depression (Sullivan et al., 2009, Shyn et al., 2011). A number of 
classical pathways were associated with depression, firstly those of monoamines, from which the 
most commonly examined pathways are serotonergic, dopaminergic and noradrenergic pathways 
and the nitric oxide pathway (Smoller, 2016).  
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1.4. Aims and hypotheses 
1) We tested whether single nucleotide polymorphisms (SNPs) at the loci for OXT, PRL and 
their receptors are associated with childhood-onset mood disorders (COMD). 
 
Based on our preliminary studies regarding the BDNF Val66Met polymorphism in 
depressed children and their siblings, to improve our knowledge about the potential 
genetic contributors to the melancholic type of depression, we examined whether an 
effect of the BDNF Val66Met polymorphism, and interaction of the BDNF Val66Met 
polymorphism with stressful life events could differentiate juvenile melancholic and non-
melancholic patients. 
 
2) Specifically, we hypothesized that: 
 
a. Melancholic and non-melancholic depressed probands are characterized by 
different BDNF Val66Met genotype and allele distributions 
b. Past exposure to stressful life events interacts with the BDNF Val66Met 
polymorphism to predict a melancholic depression phenotype 
 
Furthermore, we examined the possible association between interferon-gamma +874 T/A 
single nucleotide polymorphism and the development of a symptomatically homogenous 
type of childhood onset depression. 
 
3) We hypothesized that: 
 
Depressed probands showing and those not showing the investigated group of somatic 
symptoms are characterized by different IFN-γ +874 T/A gene and allele distributions 
 
These studies are innovatively integrating recent work on the molecular genetics of childhood-
onset MDD. 
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2. Methods 
2.1. Participants, enrolment and assessment procedures in the Childhood Onset Major 
Depression study 
In our present work we report on three different but connected studies using depressed probands 
and their unaffected siblings on a large sample, which is representative to the Hungarian 
outpatient and clinic-referred population of depressed youths as the recruitment sites supported 
more than approximately 85% of the newly referred cases during the study period. 
 
 
   
 
 
 
 
 
 
 
 
 
Figure 3. Description of the entire sample and the identified subgroups 
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Table 1. Descriptions of the samples and hypotheses 
 
Subsample 
Hypotheses 
Group Comparator group 
Study 1 
(oxytocin and 
prolactin) 
678 probands 
and 177 affected 
siblings 
- Association of OXT and PRL and their receptors with COMD 
Preliminary 
(BDNF) 
95 /210 
probands  
100 unaffected 
siblings 
Association of BDNF Val66Met 
with depression and melancholy 
Study 2 (BDNF 
X SLE) 
162 melancholic 
probands 
421 non-
melancholic 
probands 
Association of BDNF Val66Met 
with melancholy and role of 
interaction with SLE 
Study 3 
(IFNγ +874) 
55 probands 
showing somatic 
symptoms 
45 probands 
without somatic 
symptoms 
Association of IFNγ +874 with 
somatic symptoms 
 
 
The data derive from a multidisciplinary Program Project studying genetic and psychosocial risk 
factors for COMD. The project was conducted in Hungary, in collaboration with Pittsburgh 
University, NIMH grant #MH056193. The sample includes in total 716 depressed probands, 
recruited from 23 mental health facilities across the country, including 7 child and adolescent 
psychiatry inpatient units. Screening of probands was performed from 01.11.1999 to 01.07.2005. 
Signed consent from the parents and assent from the children were obtained from all subjects in 
accordance with the Hungarian National Health and the Regional Human Investigation Review 
Board guidelines, in accordance with the legal requirements in Hungary and the University of 
Pittsburgh, Pittsburgh, USA. Table 1 and figure 3 describes the entire sample and shows the 
identified subgroups. Inclusion criteria were the following:  DSM-IV diagnosis of MDD with the 
onset of the first episode from 7.0 years by age 14.9 and being free of mental retardation and 
major systemic medical disorders, with at least one biologic parent and a 7 –17.9-year-old sibling 
available. At first, children were selected on the basis of a depressive symptom screen, the short 
version of the Children's Depression Inventory (Kovacs et al., 2003), having to reach the cut-off 
score for inclusion. The instrument was selected during the course of a pilot study to maximize 
sensitivity and specificity. Screen cut-off and also screening measure used were adjusted during 
the recruitment phase in order to minimize false positives. The diagnostic procedure included an 
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audiotaped semi-structured Interview Schedule for Children and Adolescents - Diagnostic 
Version (ISCA-D), an extension of the Interview Schedule for Children and Adolescents (ISCA) 
(Sherrill et al., 2000). The interviewers were child- and adolescent psychiatrists and 
psychologists, who completed 3 months of didactic and practical training in the interview 
technique (an average of 85% symptom-agreement reached on 5 consecutive videotaped 
interviews against “gold standard” interview ratings provided by the trainers). Interrater 
reliability on ISCA-D symptoms was satisfactory.  
Ratings were obtained both for current and past symptoms of DSM-IV Axis I diagnoses 
and major DSM-III disorders (e.g. depression with melancholic features). The evaluation 
consisted of 2 different parts, conducted by different clinicians, approximately 6 weeks apart. 
The diagnostic assessment for the participants enrolled in this study has been described further in 
detail previously (Kapornai et al., 2007; Kiss et al., 2007; Liu et al., 2006). Importantly, to 
establish depressive episodes and symptoms, we performed two independent semi-structured 
diagnostic interviews during the intake procedure rated by trained clinicians, and subsequently 
evaluated by Best-Estimate Diagnostic Procedure (Maziade et al., 1992). The “Mood Disorder 
Module” of the semi-structured diagnostic interview was administered first, together with the 
Intake General Information Sheet (IGIS). A time-line with named anchors was created during the 
interview, in order to identify present and past depressive episodes (with onset and offset dates as 
punctual as possible) and to document the occurrence of any of a range of significant life events. 
The anchors consisted of both general and personal events.  
If the child had met DSM criteria for mood disorder at the first evaluation, the full semi-
structured diagnostic interview and a completion with additional self-rated scales were 
administered. Not only the child was interviewed about him/herself, but also the parent about the 
child. Pairs of senior child psychiatrists, trained as Best Estimate Diagnosticians (BEDs), 
separately reviewed all material, and then together derived consensus diagnoses and decided 
whether the child entered the “Proband” status.  
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2.1.1. Study 1. Investigating the oxytocin or prolactin gene variants 
In the investigation of oxytocin or prolactin gene variants, we included 678 families (Figure 3) 
with at least one biological parent and a proband in the statistical analyses. In Study 1, there were 
855 affected participants - probands (n = 678) and affected siblings (n = 177) met DSM-IV 
criteria for either unipolar depression (n = 838) prior to age 14 years or bipolar disorder (n = 17) 
prior to age 17 years. The mean proband age at study entry was 12.6 years [S.D. 2.32 years]. 
Probands were 55% male. Bipolar cases were included in the analyses since a significant 
proportion of unipolar children will switch as they mature (Kovacs et al., 1997; Geller et al., 
2001) - less than 1% of the entire sample had a bipolar spectrum diagnosis at intake (Dempster et 
al., 2007) -, and evidence that unipolar and bipolar illnesses share inherited risk (McGuffin et al., 
2003). 
2.1.2. Preliminary studies testing the BDNF Val66Met polymorphism in depressed children 
and their unaffected siblings 
The aim of our preliminary study on the BDNF Val66Met polymorphism was to examine the 
relationship between the polymorphism and childhood-onset depression, additionally, 
melancholy as an alternative phenotype, the somato-vegetative symptoms as phenotypic 
characteristics and stress related life events as environmental factors. Ninety-five depressive 
patients and their 100 healthy siblings without psychiatric history above 18 years of age were 
involved in this study. Probands were 50,5% and siblings were 48% male. The average age of 
the probands from this first sample was 11,35±1,8 years and that of the siblings was 18,4±1,3 
years. Depressive episodes and symptoms were examined with semi-structured interview (ISCA-
D). Melancholic phenotype was separated on the basis of the additional question of ISCA-D 
referring to the different quality of depressed mood.  
Extending our analysis, we compared 210 depressed (Figure 3) probands and their 100 
unaffected siblings. Therefore, our largest case number regarding the preliminary studies is 210. 
Screening of probands was performed from 01.11.1999. to 01.07.2005, and siblings from 
01.11.1999 to 31.05.2008. Distribution of probands by gender and age was 116 males (55.2%), 
mean age: 13.08 ±2.3 years. 
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 In this study we defined subgroups within depression according to the presence of melancholic 
symptom on the basis of an item of the diagnostic interview referring to the distinct quality of 
depressed mood. (This feeling of sadness since … is/was this different than the feeling you get 
when a friend moves away?  Is/was this like a ‘missing feeling’ or a ‘lonely feeling?  How is it 
different?  Is it like being in a dark cave?  Has anyone close to you died?  A pet?  Can you 
remember how you felt then?  How is/was your feeling now?  Did you feel any different?  In 
what way…?).  Ratings were obtained for both current and past symptoms. The distribution of 
melancholic and non-melancholic phenotypes between the depressed group was the following: 
24 (11.4%) participants currently melancholic, 16 (7.7%) with a past melancholic depressive 
episode and 4 (1.9%) both current and past melancholy. 
Siblings of child probands were subjected to the same research screening procedure and in case 
of positive screening, to the same comprehensive diagnostic assessment procedure, detailed 
above. Both probands and siblings were followed up by a yearly mail-follow-up test package 
(MFU), including: a) parental report of interim medical and psychosocial events (short version of 
our IGIS = SR-GIS) and a 26-item DSM depressive symptom checklist (DSC) and b) each 
child’s self-rated depression scale (short CDI). In case of positive screening, a diagnostic 
assessment procedure followed. All the siblings who haven’t screened positive on the follow-up 
package before 18 years of age, were invited for assessment. 100 siblings over 18 years of age 
were involved in the study as controls (48 males (48%), mean age: 18,04±1,3 years), whose 
assessment procedure excluded the existence of current as well as lifetime episode of major 
depression or any other major psychiatric morbidity.  
 
2.1.3. Study 2. Investigating the melancholic and the nonmelancholic depressed groups 
Studying the BDNF Val66MET polymorphism on an even larger sample, the depressed group 
was divided into two groups on the basis of an improved classification method investigating the 
presence of the melancholic subtype. From the COMD study sample 583 depressed probands 
were included in Study 2 (Figure 3). Melancholic subtype of depression was estimated by ISCA-
D, on the basis of the criteria for melancholic features of the DSM-IV. The differentiating 
symptoms were pervasive, nonreactive anhedonia, distinct quality of depressed mood, depression 
worse in the morning, early morning awakening, marked psychomotor retardation or agitation, 
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anorexia, weight loss and excessive and inappropriate guilt. 135 subjects met criteria for 
melancholic depression in the current time-frame, and 44 subjects had such features during a past 
episode. There were overlaps between the two groups given that some subjects had melancholy 
in both time frames. Thus, 162 subjects met criteria for melancholic depression in at least one 
time frame. The mean age of depressed subjects at first interview was 11.72 (SD=2.01) years. 
The melancholic group (N=162) had a mean age of 11.71 (SD=2.01) and the non-melancholic 
group (N=421) had a mean age of 11.76 (SD=2.01). The distribution by gender was 55.6% male 
(n=324) in the total depressed group, 46.9% male (n=76) in the melancholic group and 58.9% 
male (n=248) in the non-melancholic group (see Table 2 for further details).  
Table 2. Characteristics of the total depressed group and the melancholic and nonmelancholic patients 
 Depressed group 2 (n=583) MEL (n=162) NMEL (n=421) 
Age of onset (years) 11.7±2.0 11.7±2.0 11.7±2.0 
Male/female 324/259 76/86 248/173 
SLE (mean±SD) 6.07±2.86 5.84±3.03 6.15±2.78 
MEL, melancholic; NMEL, nonmelancholic; SLE, stressful life event.  
 
 
Life events were abstracted from a pre-coded demographic data sheet, the Intake General 
Information Sheet (IGIS), completed by clinicians as part of the intake psychiatric interview, 
using parents as informants. On the basis of the study of Mayer et al. (2009), 22 of the 26 
stressful life events were separated into five clinically meaningful groups: “Parental health”, 
“Death of close relatives”, “Sociodemographic” and “Intrafamilial”. Miscellaneous events 
formed the fifth group containing items reflecting extrafamilial life events and abuse. A 
continuous weighted total score reflecting the number of stressful life events was also computed 
from the 26 items. Both the total and the grouped scores of stressful life event items were 
weighted by age (age in years at the intake ISCA-D interview).  
 
2.1.4. Study 3. Investigating the interferon-gamma +874 T/A polymorphism 
100 Hungarian patients with childhood onset depression were involved in this study (55 
probands in the sickness behaviour (SB) group and 45 probands in the comparison group)  
(Figure 3). Diagnostic procedure included the above detailed Interview Schedule for Children 
and Adolescents - Diagnostic Version, a semi- structured interview, based on DSM-IV. Covering 
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the subject’s current episode and lifespan, we examined six somatic symptoms that characterize 
sickness behaviour (SB) and depression, too (fatigue, altered sleep patterns, psychomotor 
retardation, appetite loss, anhedonia and impaired cognitive function).  
We did not examine social withdrawal, as it is not listed in the diagnostic symptoms of major 
depressive disorder (according to DSM-IV).  
In the presence of at least five of the somatic symptoms, that were frequent, considerable, and 
noticeable and interfered with functioning, we categorized the subject into the SB group. We 
compared this SB group with those depressed subjects who did not fulfil these criteria (-sb: 
comparison group) (Table 3). 
 
Table 3. Characteristics of the subgroups 
Depressed group 3 Male (%) Female (%) Total Average age (year) 
SB group 30 (54%) 25 (46%) 55 13.25±4.09 
-sb group 25 (55%) 20 (45%) 45 13.68±5.17 
 
2.2. Diagnostic tools and questionnaires 
2.2.1. Intake General Information Sheet for Children and Adolescents (IGIS) 
The IGIS is a fully structured interview containing pre-coded item response choices. In 
the IGIS the parent is interviewed about the child’s socio-demographic/family background, 
developmental, educational, and health history, and major life events at the intake in the 
investigation.  
  
2.2.2. Interview Schedule for Children and Adolescents – Diagnostic Version Present and 
Lifetime (ISCA-D-PL) 
Major depression was diagnosed using the ISCA-D-PL semi-structured psychiatric 
interview, assessing both lifetime and current disorders in children and youths (Sherrill & 
Kovacs, 2000). Furthermore, it includes most DSM-IV Axis-I diagnoses and even some DSM-III 
symptoms. The clinicians rating is based on both the parent informants and the child’s/youth’s 
answer, by deriving a final rating for each symptom. Although the ISCA-D is designed to 
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provide information even on depression severity, this feature has not been used in the present 
studies.  
Melancholic subtype of depression was estimated by ISCA-D-PL, in case of having the DSM-IV 
diagnosis of major depression, on the basis of the additional criteria for melancholic features of 
the DSM-IV: Either of the following, occurring during the most severe period of the current 
episode: 
(1) loss of pleasure in all, or almost all activities 
(2) lack of reactivity to usually pleasurable stimuli 
Three (or more) of the following: 
(1) distinct quality of depressed mood 
(2) depression regularly worse in the morning 
(3) early morning awakening (at least two hours before usual time before the awakening) 
(4) marked psychomotor retardation or agitation 
(5) significant anorexia or weight loss 
(6) excessive or inappropriate guilt. 
 
2.2.3. Children Depression Inventory-Short Version (CDI-Short Form) 
As a part of the initial assessment, the 10-item CDI Short Form was developed. The CDI 
in its original form is a 27-item self-rated questionnaire for children and adolescents. The Short 
Form is a multi-rater assessment of depressive symptoms in youth aged 7 to 17 years correlating 
with the full inventory (r=0,89), administered and scored using paper-and-pencil format in the 
present study, providing streamline evaluation of depressive symptoms.  Each item consists of 
three choices, keyed 0 (absence of a symptom), 1 (mild symptom), 2 (definite symptom), with 
higher scores indicating increasing severity. The total score can range from 0 to 20. The cut-off 
value for clinical depression is 7 points (Mayer et al., 2006). 
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2.3. Statistical analyses and laboratory methods 
2.3.1. Statistical analyses 
To study oxytocin and prolactin gene variants, several analyses were performed using Haploview 
v 3.32 (Barrett et al., 2005), including Hardy-Weinberg equilibrium and Mendelian inheritance, 
and the transmission disequilibrium test (TDT). A corrected significance threshold was 
calculated for each gene using Nyholt’s (2004) spectral decomposition (SNPSpD) method. 
Correction by SNPSpD was followed by correction for the number of genes tested, to account for 
multiple comparisons. Haplotype blocks were defined using the Gabriel et al. (2002) criteria. All 
haplotypes with a frequency greater than 0.05 were also tested for association with COMD. 
 
 To compare melancholic depressed participants to the non-melancholic depressed ones, to 
compare melancholic depressed participants to their unaffected siblings (with no detectable Axis 
I DSM-IV disorder) and to compare probands with and without the somatic type of depression, 
we applied the following statistical methods:  
Data analysis was carried out using the software package SPSS Statistics, version 17 (SPSS Inc., 
Chicago, Illinois, USA). Group characteristics were investigated using an independent-samples t-
test and the χ2 -test. Fisher’s exact test was used to compare allele frequencies and the χ2 - test of 
statistical significance set at p less than 0.05 was used to compare genotype frequencies among 
the non-melancholic and melancholic subgroups, furthermore among melancholic probands and 
their unaffected siblings. Logistic regression models were performed to examine the total 
weighted and grouped weighted life event scores and BDNF Val66Met genotypes. We used these 
models in the total melancholic group. Main effects and possible interactions were tested using 
the likelihood ratio test (stepwise regression). In the first model (Model 1), the main effects of 
the total weighted life event score and Val66Met genotypes were tested. Second, we included the 
interaction term of total weighted life event scores and Val66Met genotypes. In the second 
model (Model 2), the genotype and the main effects of grouped life events scores were tested, 
later adding the interaction terms between grouped life event scores and Val66Met genotypes. 
The main effects of SLEs were analysed continuously as continuous score yields more 
information than dichotomous variables, yielding more sensitive results. Effect size was counted 
for the genotype-by-melancholia interaction and power analysis was carried out using GPower 
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(Faul et al., 2007). For the power calculation of the logistic regression analysis, the POWER 
procedure in SAS 9.4 was used.  
 
2.3.2. Laboratory methods 
To genotype single nucleotide polymorphisms across the OXT and PRL genes and their 
receptors, genomic DNA was isolated from blood for each participant using a high-salt method 
(Lahiri and Nurnberger, 1991). Four buccal swabs were also collected per individual for quality 
control purposes including resolution or confirmation of Mendelian inconsistencies. SNPs were 
selected for each of the four genes based on Caucasian linkage disequilibrium (LD) plots from 
the International HapMap project database (www.hapmap.org) with a minimum minor allele 
frequency (MAF) of 20% (Table 4). SNPs were genotyped independently using 50 ng DNA in a 
standard Applied Biosystems (Foster City, CA) TaqMan® assay-on-demand reaction modified 
for a 10 µl final volume. Amplified products were analysed on an AB 7500 Sequence Detection 
System.  
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Table 4. Oxytocin and prolactin system genetic marker information 
 
Gene 
 
SNP 
 
Chromosome 
 
Position 
Observed 
heterozygosity 
HWE 
p-
value 
% 
Genotyped 
Minor 
allele 
Minor 
allele 
frequency 
OXT rs2740210 20p13 3001255 0.43 0.31 98 A 0.34 
 rs2770378 20p13 3001514 0.48 0.50 97 A 0.42 
 rs4813627 20p13 3003513 0.49 0.55 98 G 0.47 
         
OXTR rs237885 3p25 8770543 0.49 0.11 100 T 0.44 
 rs2268493 3p25 8775840 0.43 0.32 96 C 0.32 
 rs237898 3p25 8783495 0.49 0.37 100 T 0.39 
         
PRL rs1205961 6p22.3 22393991 0.45 1.00 100 A 0.35 
 rs1205960 6p22.3 22396139 0.37 0.46 95 T 0.25 
 rs849886 6p22.3 22399346 0.48 0.62 100 T 0.47 
 rs1341239 6p22.3 22412183 0.47 0.78 100 A 0.39 
         
PRLR rs187490 5p13.2 35080884 0.41 0.21 100 C 0.31 
 rs249522 5p13.2 35096076 0.22 0.87 98 T 0.13 
 rs35614689 5p13.2 35134877 0.51 0.71 95 G 0.48 
 rs4703505 5p13.2 35207778 0.40 0.74 92 A 0.27 
 rs2047740 5p13.2 35239149 0.43 0.30 100 C 0.33 
 rs7727306 5p13.2 35273617 0.48 0.45 100 A 0.40 
 
 
 
In our preliminary studies on the BDNF rs6265 single nucleotide polymorphism, DNA was 
isolated from peripheral blood leukocytes and/or buccal swab. Genetic analysis: PCR, PmaCI 
restriction enzyme digestion, followed by polyacrylamide gel electrophoresis with ethidium 
bromide staining (Tsai et al., 2003). Statistical analysis was performed using SPSS software. 
 
On the sample of depressed probands in Study 2, the BDNF rs6265 single nucleotide 
polymorphism, also known as Val66Met, was genotyped using the Applied Biosystems TaqMan 
pre-designed assay C_11592758_10 (Applied Biosystems, Foster City, California, USA). For 
  
each reaction, 20 ng genomic DNA was amplified as per
volume of 10 µl in an MJ Research thermocycler (Bio
USA). Each genotyping plate was 
Sequence Detection System (software
were made manually. 
 
Genotyping of the IFNγ +874 T/A single nucleotide polymorphism has been carried out by allele 
specific PCR amplifications, followed by polyacrilamide gel electrophoresis an
ethidium bromide (DNA was isolated from blood sample or buccal swab). 
samples in the electrophoresis gel, a photo of the resulting pattern was taken (Figure 4). 
Figure 4. Representative gel picture of IFN
producer) genotype; Lane C & D: AT (medium producer) genotype; Lane 
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 the manufacturer’s dire
-Rad Laboratories, Hercules, California, 
analysed after amplification on the ABI Prism 7000 AQ5 
 v1.2.3) using the allelic discrimination option. Allele calls 
 
-ɤ +874 T/A polymorphism. M, Marker; 
E & F: TT (high producer)
ctions in a total 
d visualized by 
After migration of the 
Lane A & B: AA (low 
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3. Results 
 
3.1. Investigating the OXT, OXTR, PRL, and PRLR genes in child and youth depression 
A total of 678 families were genotyped for 16 SNPs across the OXT, OXTR, PRL, and PRLR 
genes. All SNPs were in Hardy-Weinberg equilibrium (p ≥ 0.11). Seventeen families showed 
Mendelian errors. In 11 of these, inconsistencies were not due to sample handling errors, 
according to evaluation of buccal swabs taken from the same individual as the blood sample; 
these families were suspected of nongenetic familial relationships and removed from the 
analysis. The remaining six families with Mendelian errors showed a discrepancy between the 
blood and buccal swab samples for one member of the family. In the latter cases, the swab 
sample was used to genotype the discrepant individual. DNA from blood was used to regenotype 
5% of the samples at each marker: error rates were < 1% and were explained by 
labelling/transcriptional errors.  
Two of the three SNPs of the OXT gene, showed significant results (rs2740210: allele C 
overtransmitted, χ² = 5.32, p = 0.02; rs4813627: allele G overtransmitted, χ² = 6.01, p = 0.01; see 
Table 4). After using SNPSpD, both were nominally significant (Meff = 2.35, adjusted α = 
0.021), but they were not significant after further Bonferroni correction by the number of genes 
tested (adjusted α = 0.005). No significant associations were found for any SNPs in the OXTR, 
PRL, or PRLR genes (p > 0.15 (Table 5). Only one haplotype block, spanning rs1205960 and 
rs849886 in the PRL gene, was identified. None of the haplotypes were significant.  
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Table 5. Transmission disequilibrium test results for OXT, OXTR, PRL and PRLR markers 
Gene SNP Overtransmitted 
allele 
Tr:Un x2 p 
OXT rs2740210 C 260:210 5.32 0.02¹ 
 rs2770378 G 271:238 2.14 0.14 
 rs4813627 G 299:242 6.01 0.01¹ 
      
OXTR rs237898 A 278:269 0.15 0.70 
 rs2268493 A 229:220 0.18 0.67 
 rs237885 A 270:263 0.09 0.76 
      
PRL rs1341239 T 277:246 1.84 0.18 
 rs849886 G 297:268 1.49 0.22 
 rs1205960 G 198:193 0.06 0.80 
 rs1205961 T 268:229 3.06 0.08 
      
PRLR rs7727306 A 282:279 0.02 0.90 
 rs2047740 C 259:225 2.39 0.12 
 rs4703505 T 184:162 1.40 0.24 
 rs35614689 T 272:253 0.69 0.41 
 rs249522 G 136:121 0.88 0.35 
 rs187490 T 242:230 0.31 0.58 
Tr: transmitted; Un: untransmitted.  
¹Not significant at adjusted α = 0.005. 
 
We performed two additional exploratory analyses to examine parent-of-origin effects (POEs) 
and proband sex effects for the three SNPs downstream of the OXT gene, using the default 
TDTPHASE sub-option settings of UNPHASED v2.403 (Dudbridge, 2003), followed by a 
onetailed Fisher’s Exact text, based on the hypothesis that oestrogen influences on OXT 
expression would be more relevant in transmissions to and from females. Three OXT SNPs 
revealed biased maternal transmissions of rs2740210 (allele A undertransmitted, relative risk 
(RR) = 0.68, CI = 0.46-1.03, likelihood ratio score (LRS) = 7.14, p = 0.007) and rs4813627 
(allele A undertransmitted, RR = 0.71, CI = 0.49-1.04, LRS = 6.09, p = 0.01), while paternal 
transmissions were not significant; most of the paternal transmissions were in the same direction 
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as the maternal transmissions, with no parent-of-origin effect by Fisher’s Exact Test (p’s ≥ 0.12). 
Similarly, all three OXT SNPs showed biased transmission to daughters, but proband sex effects 
were not significant after correction for multiple tests (adjusted α = 0.017) for rs2740210 (FET, p 
= 0.04) or rs2770378 (FET, p = 0.02) (Table 6). 
 
 
Table 6. OXT SNP transmissions according to the sex of the parent and proband 
 
SNP 
 
Paternal transmissions 
 
Maternal transmissions 
FET (one-
tailed) 
 Tr Un RR LRS p Tr Un RR LRS p  
rs2740210 108 95 0.88 0.83 0.36 115 78 0.68 7.14 0.007 0.12 
rs2770378 104 100 0.96 0.08 0.78 115 90 0.78 3.06 0.08 0.17 
rs4813627 111 88 0.79 2.66 0.1 125 89 0.71 6.09 0.01 0.32 
            
 
SNP 
 
Transmissions to male probands 
 
Transmissions to female probands 
FET (one-
tailed) 
 Tr Un RR LRS p Tr Un RR LRS p  
rs2740210 135 128 0.95 0.19 0.66 133 90 0.68 8.34 0.004 0.04 
rs2770378 145 152 1.05 0.16 0.68 132 96 0.73 5.71 0.02 0.02 
rs4813627 170 151 0.89 1.12 0.29 138 98 0.71 6.81 0.01 0.11 
Tr: transmitted; Un: untransmitted; RR: relative risk; LRS: likelihood ratio test statistic; FET: Fisher’s Exact test, 
one-tailed p-value (adjusted α = 0.017). 
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3.2. The preliminary studies investigating the role of BDNF Val66Met polymorphism in 
childhood onset depression 
 
We did not find significant difference in the frequency of BDNF genotypes (p=0.511) and alleles 
(Figure 5 and 6) between the depressed and the healthy sibling control groups.  
 
 
 
 
 
 
 
 
 
    
 
 
Regarding the melancholic phenotype, BDNF Val66Val genotype had a significantly higher 
frequency in the depressed group than in the unaffected siblings (p=0.024).  
We did not find significant difference in the frequency of BDNF alleles between the melancholic 
and the non-melancholic group.  
From the investigated somato-vegetative symptoms (poor concentration, memory or attention, 
insomnia, hypersomnia, weight loss or weight gain, psychomotor retardation or agitation) 
hypersomnia showed association with the frequency of Val66Met genotype (p < 0.1).  
Regarding the categorized life event groups the occurrence of psychiatric disease of family 
members showed association with BDNF Val allele.  
Figure 5. BDNF Val66Met genotype 
distribution between depressed children 
and their healthy siblings as controls 
Figure 6. BDNF Val66Met allele 
distribution between depressed children 
and their healthy siblings as controls 
DNF Val66Met genotype distribution 
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In the extended preliminary study, the melancholic subgroup of depressed probands did not show 
significantly higher Val/Val frequency than the unaffected control group (p = 0.28 and 0.37, 
respectively). The Val allele was not associated with the occurrence of melancholic subtype in 
depressive probands (p = 0.12 and 0.29) (see the Table 7 below). 
 
Table 7. Genotype and allele distributions in melancholic probands and their unaffected siblings  
 Unaffected (n=100) Melancholic subtype (n=24) 
Current 
Melancholic subtype (n=16) 
Past 
Genotype*   *** 
Met/Met 5 (5%) 1 (4.2%) - 
Val/Met 29 (29%) 11 (45.8%) 7 (43.8%) 
Val/Val 66 (66%) 12 (50%) 9 (56.2%) 
Allele**   **** 
Val 95 23 16 
Met 34 12 7 
* melancholic current vs. unaffected χ² = 2.52   p = 0.28   
** melancholic current vs.unaffected  χ²=2.47 pVal = 0.12 and χ² = 0.32 pMet = 0.57 
*** melancholic past vs. unaffected χ² = 1.97   p = 0.37   
**** melancholic past vs. unaffected χ² = 1.1 pVal = 0.29 and χ² = 1.7 pMet = 0.28 
 
 
3.3. BDNF Val66Met genotype and allele distributions in melancholic and non-melancholic 
depressed participants and examining whether the past exposure to SLEs interacts with 
BDNF to predict the melancholic subtype 
In this sample of depressed youths, 27.78% fulfilled the criteria for melancholic depression. The 
mean age at interview did not differ significantly between the melancholic and the 
nonmelancholic subgroups [t = − 0.28, p (two-tailed) = 0.78], whereas there was a statistically 
significant difference [t = − 0.262, p (two-tailed) = 0.01] in sex. Further characteristics of the 
total sample and the subsamples can be found in Table 6 (here we provided an unweighted sum 
of life events).  
Comparison of the total and grouped SLE scores did not show any significant difference between 
the two patient groups. A nonsignificant difference [t = 1.759, df. = 1, p = 0.079] was found in 
the intrafamilial SLE scores (M = 17.33 in the nonmelancholic and 15.62 in the melancholic 
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group, respectively). Table 8 shows the frequency of each life event and the life event grouping, 
together with the relative p - values.  
 
 
Table 8. Frequency of stressful life events in the melancholic and non-melancholic groups and the p-values of 
the independent sample t-statistics testing the differences of the SLE scores between those with and without 
melancholy 
 
Life event groups Frequency in the 
melancholic group 
(N=162) 
Frequency in the non-
melancholic group 
(N=421) 
 
 
 N % N % p-value 
Parental health events 
1. Medical hospitalization of biological mother 
due to somatic illness 
49 30.2 155 36.8 0.59 
2. Medical hospitalization of biological father  43 26.9 116 27.6 
3. Medical. hospitalization of stepparent 5 
 
3.1 8 1.9 
4. Physical illness of biological mother  16 9.9 46 10.9 
5. Physical illness of biological father  18 11.2 33 7.8 
6. Physical illness of stepparent  0 0.0 1 0.2 
7. Psychiatric hospitalization of biological mother  31 19.1 63 15 
8. Psychiatric hospitalization of biological father  22 13.7 57 13.5 
9. Psychiatric hospitalization of stepparent  0 0.0 6 1.4 
Death of Close Relatives Events 
10. Death of a parent 10 6.2 17 4.0 0.63 
11. Death of a close relative  107 66.0 286 67.9 
Sociodemographic Events 
12. Financial problem 40 24.7 134 31.8 0.40 
13. Move  92 56.8 222 52.7 
14. Parent unemployed 73 45.3 203 48.2 
15. Natural disaster  4 2.5 13 3.1 
16. Loss of home 5 3.1 17 4 
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Intra-familial Events 
17. Sibling birth  102 63.0 275 65.3 0.079 
18. Sibling medical hospitalization  36 22.5 139 33.0 
19. Sibling psychiatric hospitalization 12 7.4 33 7.8 
20. Family arguments 78 48.1 225 53.4 
21. Foster-care of subject 0 0.0 4 1 
22. Divorce of biological parents  61 37.7 160 38.0 
Extrafamilial Events and Abuse 
23. Abuse  44 27.2 114 27.1 0.92 
24. Teasing by peers  88 54.3 230 54.6 
25. Police contact 6 3.7 19 4.5 
26. Suspension from school 3 1.9 7 1.7 
Grouping is based on the study of Mayer et al. (2009) Ref. 24 
SLE, stressful life event 
 
In both melancholic and nonmelancholic depressed groups, the homozygous Val/Val genotype 
had the highest occurrence. The homozygous Met/Met genotype was the least common in both 
groups. Table 9 shows the genotype and allele frequencies in the total depressed group and the 
subgroups. The genotypes were in Hardy–Weinberg equilibrium, both in the total depressed 
group and in the subgroups.  
Table 9.  BDNF genotype distributions and allele frequencies in the melancholic and non-melancholic 
subgroups 
 Depressed (N=583) MEL (N=162) NMEL (N=421) 
Genotype [n (%)]    
Met/Met 18 (3.1) 4 (2.5) 14 (3.3) 
Val/Met 167 (28.6) 39 (24.1) 128 (30.4) 
Val/Val 398 (68.3) 119 (73.5) 279 (66.3) 
Allele [n (%)]    
Val 963 (82.6) 277 (85.5) 686 (81.5) 
Met 203 (17.4) 47 (14.5) 156 (18.5) 
BDNF, brain-derived neurotrophic factor; MEL: Melancholic (either current or past); NMEL: Non-melancholic 
depressed 
 
Testing our first hypothesis, the allele frequency was not significantly different across the two 
diagnostic groups (Fisher’s exact: p = 0.121). The Val/Val genotype frequency did not differ 
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significantly (χ2 = 2.80, df. = 2, p = 0.25) between the melancholic and the nonmelancholic 
group. Because of the low rate of the Met/Met genotype, genotypes were dichotomized on the 
basis of the presence of the Met allele. There was a trend among the nonmelancholic depressed 
youth of showing a slightly higher rate of the Met-containing genotype, although not statistically 
significant (Fisher’s exact: p = 0.112). The effect size (W) for our genotype-by-melancholia 
interaction was 0.12; power on such an effect size with 2 df. was 0.74. Examining our second 
hypothesis, in the total melancholic group with the Model 1 of the logistic regression, described 
in the Statistical analysis section, taking Met containing genotypes as the reference category, we 
did not find either significant main effect or significant interaction effect of the total SLEs and 
the BDNF polymorphism on the melancholy outcome. When we applied Model 2 (again the 
Met-containing genotype was considered the reference category) to examine life event groups 
separately, neither of the events contributed significantly toward the model. Main effects and 
interactions of BDNF Met-containing genotypes, total SLEs, and SLE groups as predictors in the 
model of melancholic depression are shown in Table 10. For the logistic regression analysis, 
power was 0.31 for life events, 0.56 for the presence of a Met allele, and 0.06 for the life events-
by-genotype interaction. 
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Table 10. Main effects and interactions of BDNF Met-containing genotypes, total stressful life events, and 
stressful life event groups as predictors in the model of melancholic depression in males and females 
Dependent variable Models Independent variables OR p value 
Melancholy (Females) Model 1 
 
Met-containing genotypes - .0789 
Total stressful life events - .733 
Met-containing genotypes × Total stressful life events - .385 
Model 2 Met-containing genotypes - .391 
Parental health - .893 
Death of close relatives - .187 
Sociodemographic - .631 
Intrafamilial - .111 
Extrafamilial and Abuse - .871 
Met-containing genotypes ×  
Parental health 
- 
.901 
Met-containing genotypes ×  
Death of close relatives 
- 
.894 
Met-containing genotypes × Sociodemographic - .573 
Met-containing genotypes × Intrafamilial - .126 
Met-containing genotypes × Extrafamilial and Abuse 1.05 .021 
 
Melancholy (Males) 
 
Model 1 
Met-containing genotypes - .073 
Total stressful life events - .109 
Met-containing genotypes ×  
Total stressful life events 
- 
.990 
Model 2 Met-containing genotypes - .073 
Parental health - .485 
Death of close relatives - .074 
Sociodemographic - .485 
Intrafamilial - .195 
Extrafamilial and Abuse - .419 
Met-containing genotypes ×  
Parental health 
- 
.995 
Met-containing genotypes ×  
Death of close relatives 
- 
.964 
Met-containing genotypes × Sociodemographic - .888 
Met-containing genotypes × Intrafamilial - .706 
Met-containing genotypes × Extrafamilial and Abuse - .356 
BDNF, brain-derived neurotrophic factor; OR, odds ratio 
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3.4. Investigating the association between interferon gamma +874 T/A polymorphism and 
the somatic type of depression 
In the sickness behaviour (SB) group, the frequencies of the A allele containing genotypes were 
higher, than in the comparison group, without statistically significant difference (Figure 7) (T/A: 
SB group: 60.0%, -sb group: 51.1%; A/A: SB group: 21.8%, -sb group: 13.3%; p = 0.122).  
 
Figure 7. Genotype distribution in probands with and without sickness behaviour 
SB, sickness behaviour; -sb, comparison group 
 
The comparison of allele frequencies also did not reveal statistically significant differences (T: 
SB group: 48.2%, -sb group: 61.1%; A: SB group: 51.8%, -sb group: 38.9%; p > 0.1) (Figure 8).
 
Figure 8. Allele distribution in probands with and without sickness behaviour 
SB, sickness behaviour; -sb, comparison group 
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These results did not reveal association between IFN-γ +874 polymorphism and SB. However 
we observed a tendency, being the genotypes with the A allele more frequent in the SB group. 
4. Discussion  
Our research is performed in a very large clinical sample of children and adolescents with 
MDD, even involving their siblings who are affected or not affected by the disorder, as controls. 
Overall, our results complement a growing body of literature, which suggests that MDD is 
caused by numerous interacting genetic and non-genetic factors. Even today, gene variants 
associated with MDD vulnerability have not been clearly identified (Lopizzo et al., 2015).  
 
We genotyped single nucleotide polymorphisms across the OXT and PRL genes and their 
receptors in a large Hungarian cohort of families with COMD. Our results show a trend towards 
association of two OXT SNPs, rs2740210 and rs4813627, with COMD, not significant after 
correction for multiple testing. Supplementary analyses initially suggested proband sex effects 
for OXT SNPs rs2740210 and rs2770378, but were not significant after multiple testing 
corrections. OXT lies in a segmental duplication region of human chromosome 20 and shares 
high sequence homology in the first two exons to the arginine vasopressin (AVP) gene. The OXT 
and AVP genes lie tail-to-tail and are separated by a 10 kb intergenic region (IGR); AVP and 
vasopressin V1b receptor gene ( (AVPR1B) genetic polymorphisms have both been significantly 
associated with COMD in this sample (Dempster et al., 2007, 2009). The three OXT SNPs 
genotyped in the present study reside within 2 kb of the 3’ end of the OXT gene. Transgenic rat 
and mouse studies of the OXT and AVP genes have shown that the IGR contains regulatory 
sequences responsible for cell-specific OXT expression in oxytocinergic magnocellular neurons 
(MCNs) (Murphy and Wells, 2003). The observation that the two OXT SNPs showed a 
nonsignificant trend for affected daughters, is of note in light of OXT sex effects reported in the 
literature (Richard and Zingg, 1990; Cushing and Carter, 2000). To our knowledge, this is the 
first genetic association study of OXT and PRL variants in a pediatric mood disorder sample. 
Four studies have found associations between OXTR gene variations and autism (Wu et al., 2005; 
Ylisaukko-oja et al., 2005; Jacob et al., 2007; Gregory et al., 2009) and recent evidence has 
implicated the OXTR in maternal sensitive responsiveness with their 2-year-old toddlers 
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(Bakermans Kranenburg and van Ijzendoorn, 2008). A haplotype of three OXTR SNPs that we 
did not examine has recently been associated with negative affect and loneliness (Lucht et al., 
2009). Another investigation noted an association between two OXTR SNPs and major 
depression (Costa et al., 2009); we studied three different loci and provided broader SNP 
coverage of the OXTR, with a childhood-onset sample. There were more missing fathers than 
missing mothers in our sample. We did not estimate missing parental genotypes. Since a missing 
parental genotype means the entire family is excluded from the analysis, the relatively larger 
number of missing fathers will reduce our power, but not influence the relative numbers of 
parental transmissions tested. We studied a moderately large, well-characterized sample. 
Statistical methods used were robust to population stratification. Corrections for multiple tests 
were conservative. We estimate 678 families provide a power of 0.86, given the assumptions of a 
α=0.05, population frequency of 2%, additive model of inheritance, genotype relative risk of 1.4, 
minor allele frequency of 0.41 (mean minor allele frequency for OXT SNPs = 0.41) and complete 
linkage between risk and disease variants (Purcell et al., 2003). We report evidence that was 
initially suggestive of possible association between two OXT SNPs (rs2740210 and rs4813627) 
and COMD. The results survived spectral decomposition, but were not significant after 
correcting for the number of genes tested. OXTR, PRL and PRLR SNPs were not associated with 
COMD. In secondary analyses, the relative significances of association for two OXT SNPs were 
increased with parental and proband sex effect analyses. A trend towards proband sex effects to 
daughters failed to reach statistical significance after correcting for multiple tests. Considering 
the OXT SNPs are located in a putative regulatory region, our exploratory analyses by parent and 
proband sex are of interest as they may be relevant to epigenetic effects (Kaminsky et al., 2006). 
  
Our second study completes the investigation of the genetic background of depression 
using alternative phenotypes. We were particularly interested in finding subtypes/alternative 
phenotypes of depression, as well as finding a trait marker for major depression, because such 
factors could be helpful in finding susceptibility genes. Given that MDD as defined by the DSM-
IV is a complex disorder, finding susceptibility genes may be facilitated using alternative, more 
homogenous depression phenotypes. However, even factors other than genetic vulnerability and 
diagnostic procedure must be considered to explain the development of MDD (Hosang et al., 
2014). Despite the clinical utility and validity of the melancholic phenotype of depression, a 
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debate has been ongoing on the relevance of the subtype, suggesting that further research is 
needed (Hadzi-Pavlovic and Boyce, 2012) to define its biological features. After that the results 
of our preliminary study showed that the BDNF Val66Met polymorphism might play a role in 
the onset of melancholic type of depression, we decided to perform the analyses on a larger 
database and with improved criteria for melancholic depression. 
 Consequently, we studied the contribution of the BDNF polymorphism and its 
interaction with SLE toward early onset melancholic depression. The frequency of melancholia 
in our sample was in the range of the previously reported prevalences of 20% to almost 50% in 
juvenile samples (Ryan et al., 1987; Kolvin et al., 1991; Ambrosini et al., 2002). The ratio of 
females was significantly higher in the melancholic than in the non-melancholic group [t = 
−0.262, p (two-tailed) = 0.01], suggesting that females are more prone to developing the early-
onset melancholic phenotype. The current literature establishes that girls show more depressive 
symptoms than boys (Wade et al., 2002; Hankin et al., 2007); however, there is some 
inconsistency in the findings (Chen et al., 2012), which may be because of methodological, age, 
and ethnic differences in the sample populations. Although in a preliminary study of Quinn et al. 
(2012) and in the study of Guo et al. (2015), no significant differences were found in the 
melancholic, non-melancholic, and control groups for sex or age, the difference compared with 
our findings may be because of their focus on the adult population in addition to a smaller 
sample size, which decreases the chances of finding a significant difference. Our result may 
represent an interesting suggestion for future research as the presence of the subtype might 
influence treatment response (Rush et al., 2008) and complications. According to a study of Gold 
et al. (2002), common medical complications of different subtypes of depression may occur 
because of different underlying mechanisms. In the genotypic and allelic association analysis, we 
found elevated Val/Val genotype frequency in the melancholic group. Our analysis, however, 
could not be used to discriminate between the melancholic and the non-melancholic groups. The 
calculated effect size and the power analysis carried out for our genotype-by-melancholia 
interaction suggests that small to medium effects would have been detected if present. Our 
results partly correlate with the study of Quinn et al. (2012), showing that no significant 
relationship was found between the BDNF genotype and groups. However, they found that the 
gene-by-environment interaction effect is expected to provide a better prediction for melancholic 
depression. The explanation for the different but not contradictory results is that we examined 
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biological features discriminating the melancholic versus the non-melancholic phenotype within 
a depressed sample, whereas Quinn et al. (2012) compared the melancholic and the non-
melancholic group of patients with healthy controls. Power analysis for the logistic regression 
analysis suggests that our sample was adequate to detect the main effects of life events or 
genotype if they were medium to large, but could only detect interaction effects if they were 
quite large.  
In our third study we investigated the (+874) T/A genotypes given the information that 
they have previously been studied in connection with the risk of IFN-alpha-induced depression, 
the presence of T alleles representing a risk for the development of this disease (Oxenkrug et al., 
2014). Our case control study investigating directly the role of interferon-γ, performed on a well-
defined subgroup of depressed children, however, did not reveal any significant difference in the 
genotype or allele distribution between subjects with the somatic type of depression and the 
comparison group. We observed a tendency that failed to attain significance at conventional 
level, being the genotypes with the A allele more frequent in the SB group. Further investigation 
may thus be needed with an increased number of subjects.  
Since the underlying genetics has proved to be highly complex, identifying the genetic 
determinants for individual differences in the susceptibility to MDD is amongst the greatest 
challenges. 
An illustrative example on the complexity of the genetic background of depression is 
given by that interferon treatment may modulate 5-HTT activity levels (Morikawa et al., 1998). 
A repeat length polymorphism in the promoter region of this gene has been shown to affect the 
rate of serotonin uptake and may play a role in depression-susceptibility. In human placental 
choriocarcinoma cells, a 3-hour treatment with IFN-γ increased levels of 5-HTT mRNA and a 
treatment with IFN-γ for 3-6 hours also increased 5-HTT uptake activity. These data suggest that 
IFN-induced psychiatric effects may be modulated by regulation of 5-HTT transcription. 
The power and performance of the methods trying to determine the molecular genetic 
background of depression may be further improved by integrating biological information at the 
systemic level. To overcome the limitations of the case control approaches, sets of the genes 
carrying out biochemical processes related to the functioning of neural systems can be 
investigated in the future.  
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Strengths and Limitations 
Although the sample size would ideally be larger, the above described studies have 
several methodological strengths. We note that our melancholic group is a well-defined subgroup 
within the depressed patients thanks to the diagnoses established through a very rigorous 
procedure, described in the materials and methods section, using clinician administered semi-
structured interviews to obtain the optimal collection of biographical and contextual information. 
Life events were measured by researcher administered questionnaires. The present study on 
oxytocin and prolactin genes is the first genetic analysis to examine the association between 
variants in these neuroendocrine genes and depression with onset in childhood. Furthermore, to 
our knowledge, this is the first study to investigate the differentiating effect of the BDNF 
genotype and the G×E interaction on the melancholic phenotype in a large sample of depressed 
young patients, which was representative of the Hungarian population. 
As the parents were providing information on their children’s SLEs, we had limited 
information on some of them, for example teasing. Though face-to-face interviews by clinically 
trained assessors, the use of common phrases, and the use of timelines with named “anchors” 
during the interview may facilitate retrospective recall (Buka et al., 2004).   
Given the complexity of Model 2 investigating the interaction of stressful life events with 
the BDNF Val66Met polymorphism, the particular model would only be able to detect large 
effects, which represents a limitation of our study.  
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Conclusions 
 
We found no association between oxytocin and prolactin gene variants and childhood-
onset mood disorders. The performed exploratory analyses by parent and proband sex are of 
interest as they may be relevant to epigenetic effects. We didn’t find association between the 
melancholic subtype of major depression and the BDNF genotype and stressful life event 
interaction and the somatic subtype of childhood-onset major depression and the interferon-
gamma +874 T/A polymorphism in this clinic-referred population of depressed youths. 
In our study, females are more prone to develop the early-onset melancholic phenotype. 
This results contributes to the prevention and treatment of the melancholic type of childhood-
onset major depression, as consequences can be lessened by focusing on risk groups in early 
stages. However, additional research and empirical work is needed in this area to further 
understand the contribution of the early-onset phenotype. 
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Figure 1. BDNF polymorphism. The courtesy of Ágnes Fehér.  
 
Figure 2. Cellular transport and secretion of BDNF.From the article titled the Yin and yang of 
neurotrophin action by Bai Lu, Petti T. Pang & Newton H. Woo (2005). Nature Reviews 
Neuroscience 6, 603-614. 
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